Bisoprolol
- Generic Name
- Bisoprolol
- Brand Names
- Ziac
- Drug Type
- Small Molecule
- Chemical Formula
- C18H31NO4
- CAS Number
- 66722-44-9
- Unique Ingredient Identifier
- Y41JS2NL6U
- Background
Bisoprolol is a cardioselective β1-adrenergic blocking agent used to treat high blood pressure. It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs. Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternati...
- Indication
Bisoprolol is indicated for the treatment of mild to moderate hypertension. It may be used off-label to treat heart failure, atrial fibrillation, and angina pectoris.
- Associated Conditions
- Atrial Fibrillation, Cardiovascular Events, Chronic Stable Angina Pectoris, Heart Failure, Hypertension, Mild Hypertension, Premature Ventricular Contraction (PVC), Supraventricular Arrhythmias, Moderate Hypertension, Perioperative arrhythmia
- Associated Therapies
- -
Determination of Drug Levels for Pharmacotherapy of Heart Failure
- Conditions
- Interventions
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- University Hospital Ostrava
- Target Recruit Count
- 100
- Registration Number
- NCT06035978
- Locations
- 🇨🇿
University Hospital Ostrava, Ostrava, Czech Republic, Czechia
Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
- Conditions
- Interventions
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 122
- Registration Number
- NCT05730413
- Locations
- 🇪🇬
El-Demerdash Cardiac Academy Hospital, Cairo, Egypt
Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
- Conditions
- Interventions
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Morten Steen Kvistholm Jensen
- Target Recruit Count
- 100
- Registration Number
- NCT05569382
- Locations
- 🇩🇰
Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark
🇩🇰Department of Cardiology, Odense University Hospital, Odense, Denmark
🇩🇰Department of Cardiology, Zealand University Hospital, Roskilde, Denmark
Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2022-09-16
- Lead Sponsor
- University of Monastir
- Target Recruit Count
- 30
- Registration Number
- NCT05540600
- Locations
- 🇹🇳
Fattouma Bourguiba University hospital, Monastir, Tunisia
Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Damanhour University
- Target Recruit Count
- 127
- Registration Number
- NCT05536271
- Locations
- 🇪🇬
Damanhour University, Damanhūr, Behira, Egypt
Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease
- First Posted Date
- 2022-03-24
- Last Posted Date
- 2022-03-24
- Lead Sponsor
- Charite University, Berlin, Germany
- Target Recruit Count
- 132
- Registration Number
- NCT05294887
- Locations
- 🇨🇭
Universitäres Herzzentrum Zürich, Universitätsspital Zürich, Zürich, Switzerland
🇩🇪Kerckhoff-Klinik gGmbH, Bad Nauheim, Germany
🇩🇪Herz- und Diabeteszentrum NRW, Bad Oeynhausen, Germany
Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
- Conditions
- Interventions
- First Posted Date
- 2022-01-03
- Last Posted Date
- 2022-01-03
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT05175066
- Locations
- 🇮🇷
Rasool Akram hospital, Tehran, Iran, Islamic Republic of
Activation of Brown Adipose Tissue Metabolism Using Mirabegron
- Conditions
- Interventions
- First Posted Date
- 2021-03-30
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Université de Sherbrooke
- Target Recruit Count
- 9
- Registration Number
- NCT04823442
- Locations
- 🇨🇦
Centre de recherche du CHUS, Sherbrooke, Quebec, Canada
Comparative Study Between the Efficacy of Verapamil and Bisoprolol on Reduction of Bleeding During Endoscopic Sinus Surgery Under General Anaesthesia.
- Conditions
- Interventions
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 135
- Registration Number
- NCT04356196
- Locations
- 🇪🇬
Faculty of medicine Assiut university, Assiut, Egypt
Preventing Adverse Cardiac Events in COPD
- Conditions
- Interventions
- First Posted Date
- 2019-04-17
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 280
- Registration Number
- NCT03917914
- Locations
- 🇦🇺
Westmead Hospital, Sydney, New South Wales, Australia
🇦🇺Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇦🇺Campbelltown Hospital, Campbelltown, New South Wales, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.